In yesterday’s Wall Street session, Guardant Health Inc. (NASDAQ:GH) shares traded at $36.14, down -4.88% from the previous session.
20 analysts cover Guardant Health Inc. (NASDAQ:GH), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $85.00 and a low of $30.00, we find $53.00. Given the previous closing price of $37.99, this indicates a potential upside of 39.51 percent. GH stock price is now 2.29% away from the 50-day moving average and 6.55% away from the 200-day moving average. The market capitalization of the company currently stands at $4.08B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 3 analysts and a buy rating from 17. Brokers who have rated the stock have averaged $54.18 as their price target over the next twelve months.
In other news, Joyce Meghan V., Director sold 2,766 shares of the company’s stock on Jun 15. The stock was sold for $103,863 at an average price of $37.55. Upon completion of the transaction, the Director now directly owns 4,224 shares in the company, valued at $0.15 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 09, Chief Information Officer Kalia Kumud bought 2,981 shares of the business’s stock. A total of $97,498 was incurred on buying the stock at an average price of $32.71. This leaves the insider owning 5,193 shares of the company worth $0.19 million. Insiders disposed of 42,783 shares of company stock worth roughly $1.55 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in GH stock. A new stake in Guardant Health Inc. shares was purchased by JACOBS LEVY EQUITY MANAGEMENT, INC during the first quarter worth $31,241,000. NORGES BANK invested $28,444,000 in shares of GH during the first quarter. In the first quarter, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) acquired a new stake in Guardant Health Inc. valued at approximately $28,153,000. D. E. SHAW & CO., INC. acquired a new stake in GH for approximately $17,733,000. SQUAREPOINT OPS LLC purchased a new stake in GH valued at around $9,398,000 in the second quarter.
On Wednesday morning Guardant Health Inc. (NASDAQ: GH) stock kicked off with the opening price of $37.01. During the past 12 months, Guardant Health Inc. has had a low of $20.67 and a high of $62.75. The fifty day moving average price for GH is $35.45 and a two-hundred day moving average price translates $33.85 for the stock.
According to the Diagnostics & Research Company, earnings per share came in at -$1.3, beating analysts’ expectations of -$1.31 by 0.01. This compares to -$1.21 EPS in the same period last year. The company reported revenue of $128.71 million for the quarter, compared to $96.1 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 33.94 percent. For the current quarter, analysts expect GH to generate $129.41M in revenue.
